[1]
2018. Implications of Programmed Death Ligand-1 Positivity in Non-Clear Cell Renal Cell Carcinoma. Journal of Kidney Cancer. 5, 4 (Oct. 2018), 6–13. DOI:https://doi.org/10.15586/jkcvhl.2018.107.